Alpha Teknova (NASDAQ:TKNO) Stock Price Down 11%

Alpha Teknova, Inc. (NASDAQ:TKNOGet Free Report) shares traded down 11% on Tuesday . The stock traded as low as $2.41 and last traded at $2.50. 118,217 shares changed hands during trading, an increase of 702% from the average session volume of 14,735 shares. The stock had previously closed at $2.81.

Analyst Upgrades and Downgrades

Separately, BTIG Research downgraded shares of Alpha Teknova from a “buy” rating to a “neutral” rating in a research report on Tuesday, March 12th.

Check Out Our Latest Report on TKNO

Alpha Teknova Trading Down 11.0 %

The company has a current ratio of 5.14, a quick ratio of 3.84 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $102.05 million, a PE ratio of -2.16 and a beta of 0.23. The stock has a 50 day moving average price of $3.01 and a 200-day moving average price of $2.75.

Institutional Investors Weigh In On Alpha Teknova

Hedge funds and other institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. grew its position in Alpha Teknova by 27.9% during the first quarter. JPMorgan Chase & Co. now owns 6,571 shares of the company’s stock valued at $91,000 after buying an additional 1,435 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Alpha Teknova by 21.6% during the 2nd quarter. Goldman Sachs Group Inc. now owns 12,806 shares of the company’s stock worth $108,000 after acquiring an additional 2,279 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Alpha Teknova by 2.1% during the 4th quarter. Geode Capital Management LLC now owns 126,055 shares of the company’s stock valued at $710,000 after acquiring an additional 2,593 shares during the period. Schonfeld Strategic Advisors LLC increased its stake in shares of Alpha Teknova by 15.9% in the 2nd quarter. Schonfeld Strategic Advisors LLC now owns 45,300 shares of the company’s stock worth $121,000 after purchasing an additional 6,200 shares in the last quarter. Finally, Conestoga Capital Advisors LLC raised its holdings in Alpha Teknova by 4.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock worth $923,000 after purchasing an additional 9,800 shares during the period. Hedge funds and other institutional investors own 13.81% of the company’s stock.

Alpha Teknova Company Profile

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Read More

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.